Management ChangeJun 10, 2026, 04:22 PM
Eikon Therapeutics Appoints Ma. Fatima D. Francisco to Board
AI Summary
Eikon Therapeutics, Inc. announced the appointment of Ma. Fatima D. Francisco to its Board of Directors as a Class I director, effective June 15, 2026. Ms. Francisco will also join the Compensation Committee. Her compensation package includes an annual retainer of $50,000 and an initial option to purchase 85,937 shares of common stock at an exercise price of $8.96 per share, vesting monthly over four years.
Key Highlights
- Eikon Therapeutics appointed Ma. Fatima D. Francisco as a Class I director, effective June 15, 2026.
- Ms. Francisco will serve until the 2027 annual meeting of stockholders.
- She will initially serve on the Compensation Committee of the Board.
- Ms. Francisco will receive an annual retainer of $50,000 for Board service.
- She was granted an option to purchase 85,937 shares of common stock.
- The option has an exercise price of $8.96 per share.
- The option vests in 48 substantially equal monthly installments.
Price Impact
More from EIKN